PRRT2 and prostate cancer: In addition, a previous study reported that LPA promotes ROS production by activating protein kinase C (PKC) in PC-3 human prostate cancer cells [33], and LPA induces inflammation through the mitogen-activated protein kinase (MAPK) pathway [34, 35].